Postmenopausal women who take fish oil supplements may have a one-third lower risk for developing breast cancer than those who don't use supplements, according to study results.
Postmenopausal women who take fish oil supplements may have a one-third lower risk for developing breast cancer than those who don't use supplements, according to the results of a recent observational, case-control study.
The study involved 35,000 postmenopausal women between the ages of 50 and 76 years participating in the VITamins And Lifestyle (VITAL) Cohort. The women, who resided in western Washington state, completed a 24-page questionnaire that included questions about current and past use of fish oil and other supplements. They were followed for an average of 6 years, during which time 880 women were diagnosed with the breast cancer.
The study found that current, regular use of fish oil supplements reduced the risk for breast cancer (hazard ratio, 0.68; 95% confidence interval [CI], 0.50-0.92). The reduced risk remained even after adjusting for a number of known and suspected risk factors for breast cancer, including older age, obesity, heavy drinking, and sedentary lifestyle. The results held for ductal cancers but not for lobular disease. Ten-year average use of fish oil was also suggestive of reduced risk (P trend=.09).
Brasky TM, Lampe JW, Potter JD, Patterson RE, White E. Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) cohort. Cancer Epidemiol Biomarkers Prev. 2010;19(7):1696-1708.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More